Wells Fargo’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
Other funds holding LABU
TAA
TI
TRCT
GS
Wells Fargo's LABU Position: Q1 2024 in Review
Wells Fargo sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2024, closing a stake of 10 shares — an estimated $1.22K sold.
Wells Fargo first reported a position in LABU in Q1 2016 and held it in 2 quarters. The position peaked at $7K in Q1 2016. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2024.
- Wells Fargo reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2024 after selling out during the quarter.
- Wells Fargo sold 10 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2024, an estimated $1.22K.
- Wells Fargo first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2016 and held it in 2 quarters.
- Wells Fargo's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $7K in Q1 2016.
- 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2024.
Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.